Krónikus vesebetegség: vizsgálatok itt: Bulgária
12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Byala, Dupnitsa, Gabrovo, Gotse Delchev, Pernik, Plovdiv, Ruse, Sandanski, Sevlievo, Sliven, Sofia, Sofiya, Varna, Veliko Tirnovo
- Életkor
- 18 év and over
- People
- 5000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - 3. fázisTaking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Gabrovo, Pazardzhik, Plovdiv, Ruse, Sofia, Sofiya, Yambol
- Életkor
- 50 év and over
- People
- 7140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - 1. fázisNot yet taking people in BulgáriaA Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery Disease
- Where
- Sofia
- Életkor
- 40 év to 80 év
- People
- 36 worldwide
- Run by
- Bayer
See details and how to joinNCT07431294 · EU 2025-522335-34-00 - 3. fázisTaking peopleA Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
- Where
- Plovdiv, Sofia, Stara Zagora
- Életkor
- 1 év to 18 év
- People
- 100 worldwide
- Run by
- Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00 - 3. fázisTaking peopleA Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Where
- Blagoevgrad, Nova Zagora, Pleven, Plovdiv, Sandanski, Sevlievo, Sofia, Stara Zagora, Varna
- Életkor
- 18 év to 99 év
- People
- 2800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07624305 · EU 2026-526114-90-00 - 2/3. fázisTaking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Dobrich, Gabrovo, Lom, Montana, Plovdiv, Sliven, Smolyan, Sofia, Stara Zagora
- Életkor
- 18 év and over
- People
- 3110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - 2. fázisTaking peopleA Phase IIb study to evaluate the effect of combination of dapagliflozin and baxdrostat compared with baxdrostat alone in participants with chronic kidney disease and high blood pressure
- Where
- Sofia, Yambol
- Életkor
- 18 év and over
- People
- 18 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-522407-23-00 · EU 2025-522407-23-00 - 3. fázisTaking peopleEfepoetin alfa for treatment of anemia in chronic kidney disease on dialysis
- Where
- Blagoevgrad, Dobrich, Gabrovo, Montana, Plovdiv, Sliven, Sofia, Sofiya, Varna
- Életkor
- 18 év and over
- People
- 337 worldwide
- Run by
- Genexine Inc.
See details and how to join2023-503634-50-01 · EU 2023-503634-50-01 - 3. fázisTaking peopleA Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Where
- Botevgrad, Byala Slatina, Pleven, Plovdiv, Sofia, Sofiya, Varna, Yambol
- Életkor
- 18 év and over
- People
- 7000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Where
- Dupnitsa, Haskovo, Kyustendil, Pleven, Plovdiv, Ruse, Stara Zagora, Varna
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00 - 3. fázisTaking peopleA Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
- Where
- Blagoevgrad, Dobrich, Gabrovo, Montana, Pazardzhik, Plovdiv, Rousse, Sliven, Sofia, Varna
- Életkor
- 18 év and over
- People
- 429 worldwide
- Run by
- Genexine, Inc.
See details and how to joinNCT06466785 - 2. fázisTaking peopleA Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- Where
- Bankya, Kozloduy, Smolyan, Sofia, Sofiya, Varna
- Életkor
- 18 év and over
- People
- 465 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00